
2019
Healthcare R&D Center opened
The Healthcare R&D Center develops technologies utilizing analytical measurement technology and medical imaging technology. It seeks to address social challenges by engaging in external collaboration to deepen understanding of the life sciences, contribute to an aging society with science and technology, and support food product development to promote health.

2020
COVID-19 detection reagent kit was launched in Japan
Shimadzu developed the Ampdirect™ 2019-nCoV Detection Kit using unique Ampdirect technology to facilitate and accelerate PCR testing of biological samples.

Shimadzu launched "AutoAmp", a fully-automatic PCR testing system for clinics.
Contributes to Japan’s COVID-19 testing capabilities
2021
Shimadzu launched BresTome, the world's first specialized TOF-PET system for head and breast examinations

Shimadzu joined the RE100 global environmental initiative
The Shimadzu Group has pledged to use 100% renewable energy sources for electricity used in its business activities in Japan and overseas by 2050, and will promote energy-saving initiatives and the use of renewable energy sources to reduce CO2 emissions.

2022
SHIMADZU Future Collaboratory opened in Keihanna Science City
The center is a space for co-creation through open innovation to advance and diversify research and development and new business formation. It engages in research and development for cutting-edge and highly original technologies including advanced analysis, brain and five senses, innovative biotechnology, and artificial intelligence.

Nissui Pharmaceutical (now Shimadzu Diagnostics) became a wholly-owned subsidiary of Shimadzu
Nissui Pharmaceutical Co., Ltd., engaged in research and development and sales of clinical reagents, joined the Shimadzu Group, creating synergies in the areas of clinical diagnostics, microbiological testing, and cell-related business.
2023
Shimadzu Tokyo Innovation Plaza opened in Kawasaki City, Kanagawa
Shimadzu Tokyo Innovation Plaza promotes development of applied technologies for analytical and measuring instruments, provides customer technical support, and strengthens open innovation. Its goal is to create new value in world-class research areas.

2024
Shimadzu Scientific Instruments, Inc. (SSI) opened R&D center; development capabilities for pharma business expansion strengthened

Logistics, laboratory, and systems GC assembly functions strengthened to expand operations; Shimadzu Middle East & Africa FZE (SMEA) built a new head office












